VC
DVAX

Vivo Capital’s Dynavax Technologies DVAX Stock Holding History

Vivo Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-359,827
Closed -$3.47M – 30
2017
Q2 		$3.47M Sell
359,827
-1
-0% -$6 0.87% 18
2017
Q1 		$2.14M Hold
359,828
– – 0.63% 20
2016
Q4 		$1.42M Hold
359,828
– – 0.47% 22
2016
Q3 		$3.77M Hold
359,828
– – 1.18% 16
2016
Q2 		$5.25M Buy
359,828
+2,073
+0.6% +$35.4K 1.43% 14
2016
Q1 		$6.88M Buy
+357,755
New +$7.23M 1.73% 16

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Vivo Capital's DVAX Position: Q3 2017 in Review

Vivo Capital sold out of Dynavax Technologies (DVAX) in Q3 2017, closing a stake of 359,827 shares — an estimated $3.47M sold.

Vivo Capital first reported a position in DVAX in Q1 2016 and held it in 6 quarters. The position peaked at $6.88M in Q1 2016. 119 funds tracked by Wall St. Rank hold DVAX as of Q3 2017.

  • Vivo Capital reported no remaining Dynavax Technologies position as of Q3 2017 after selling out during the quarter.
  • Vivo Capital sold 359,827 Dynavax Technologies shares in Q3 2017, an estimated $3.47M.
  • Vivo Capital first reported a position in Dynavax Technologies in Q1 2016 and held it in 6 quarters.
  • Vivo Capital's Dynavax Technologies position peaked at $6.88M in Q1 2016.
  • 119 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2017.

Based on Vivo Capital's 13F filing for Q3 2017, filed 13 Nov 2017.